SARS-CoV-2 epitopes inform future vaccination strategies

SARS-CoV-2 epitopes inform future vaccination strategies

All currently approved COVID-19 vaccines utilize the spike protein as their immunogen. SARS-CoV-2 variants of concern (VOCs) contain mutations in the spike protein, enabling them to escape infection- and vaccination-induced immune responses to cause reinfection. New vaccines are hence being research...

Full description

Bibliographic Details
Main Authors:	Areez Shafqat, Mohamed H. Omer, Omar Ahmad, Mahnoor Niaz, Humzah S. Abdulkader, Shameel Shafqat, Ali Hassan Mushtaq, Abdullah Shaik, Ahmed N. Elshaer, Junaid Kashir, Khaled Alkattan, Ahmed Yaqinuddin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 broadly neutralizing antibodies epitopes omicron T-cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041185/full

Similar Items

Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
by: Ahmed Yaqinuddin, et al.
Published: (2021-08-01)

Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
by: Areez Shafqat, et al.
Published: (2022-03-01)

COVID-19 associated cardiac disease: Is there a role of neutrophil extracellular traps in pathogenesis?
by: Amal Feiroze Farouk, et al.
Published: (2021-12-01)

Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
by: Areez Shafqat, et al.
Published: (2022-06-01)

COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response
by: Junaid Kashir, et al.
Published: (2021-03-01)

Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus
by: Areez Shafqat, et al.
Published: (2022-08-01)

Applying integrated video assisted learning approaches for medical clerkship – potential adaptations in the post-COVID-19 era
by: Ahmed Yaqinuddin, et al.
Published: (2020-10-01)

Linear epitopes of PRRSV-1 envelope proteins ectodomains are not correlated with broad neutralization
by: Jaime Castillo-Pérez, et al.
Published: (2024-10-01)

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
by: Jéssica Pires Farias, et al.
Published: (2023-12-01)

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
by: Hebang Yao, et al.
Published: (2023-12-01)

Kawasaki like disease in SARS-CoV-2 infected children – a key role for neutrophil and macrophage extracellular traps
by: Ahmed Yaqinuddin, et al.
Published: (2021-07-01)

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
by: Lingyan Cui, et al.
Published: (2024-06-01)

Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion
by: Lisa C. Lindesmith, et al.
Published: (2018-02-01)

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
by: Andrey P. Rudometov, et al.
Published: (2019-08-01)

Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses
by: Chenchen Jiao, et al.
Published: (2023-02-01)

Neutrophil extracellular traps and long COVID
by: Areez Shafqat, et al.
Published: (2023-09-01)

A Supercluster of Neutralizing Epitopes at the Interface of Ricin’s Enzymatic (RTA) and Binding (RTB) Subunits
by: Amanda Y. Poon, et al.
Published: (2017-11-01)

Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
by: Yudong Wang, et al.
Published: (2023-03-01)

Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
by: Masaud Shah, et al.
Published: (2023-09-01)

In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a Semi-Immune Phage Display Library
by: Edith González-González, et al.
Published: (2022-09-01)

Research progress on neutralizing epitopes and antibodies for the Rabies virus
by: Chenjuan Shi, et al.
Published: (2022-12-01)

The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran
by: Mehdi Shabani, et al.
Published: (2025-01-01)

A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire
by: Meng Yu, et al.
Published: (2022-07-01)

Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
by: Areez Shafqat, et al.
Published: (2023-07-01)

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
by: Areez Shafqat, et al.
Published: (2023-07-01)

A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
by: Emma Parker Miller, et al.
Published: (2021-09-01)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
by: Dongping Zhao, et al.
Published: (2022-09-01)

Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development
by: Huixiong Deng, et al.
Published: (2025-01-01)

Leukotoxin of Bibersteinia trehalosi Contains a Unique Neutralizing Epitope, and a Non-Neutralizing Epitope Shared with Mannheimia haemolytica Leukotoxin
by: Arumugam Murugananthan, et al.
Published: (2018-05-01)

Tackling the glial scar in spinal cord regeneration: new discoveries and future directions
by: Areez Shafqat, et al.
Published: (2023-05-01)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
by: Meredith E. Davis-Gardner, et al.
Published: (2020-02-01)

The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant
by: Weeraya Thongkum, et al.
Published: (2022-06-01)

Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10
by: Hanyu Zhu, et al.
Published: (2022-12-01)

The role of the oocyte activation factor PLCzeta in human male factor infertility
by: Kashir, J, et al.
Published: (2011)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
by: Raziyeh Zareh-Khoshchehreh, et al.
Published: (2023-01-01)

Identification of a conserved neutralizing epitope in Seneca Valley virus VP2 protein: new insight for epitope vaccine designment
by: Wei Wen, et al.
Published: (2022-04-01)

EDiP: the Epitope Dilution Phenomenon. Lessons learnt from a malaria vaccine antigen and its applicability to polymorphic antigens
by: Kwadwo Asamoah Kusi, et al.
Published: (2018-01-01)

Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
by: Bo-Seong Jeong, et al.
Published: (2022-11-01)

Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
by: Bo-Seong Jeong, et al.
Published: (2022-12-01)